Episode 206: biomarkers for dementia, toileting, bleeding risk, and diagnosing volume overload.
Join primary care faculty Gary Ferenchick, Kate Rowland, Henry Barry and Mark Ebell as they discuss 4 important new studies: the value (?) Of biomarkers in cognitive impairment, toilet training, bleeding risk with apixaban versus rivaroxaban for VTE, and diagnosing volume overload in adults from the JAMA Rational Clinical Exam series.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Primary Care Update
Episode 211: semaglutide for AUD, preventing post-vax syncope, PCR panel for RTI, fluvoxamine for long-COVID
Episode 210: screen time, stopping levothyroxine, new mRNA flu vaccine, and NAS supplements.
Episode 209: cocoa, best UTI antibiotic, LAA closure for AF, and evolocumab for primary (sort of) prevention
Episode 208: drinks with diabetes, new Paxlovid trial, antiplatelet agents in stroke, and dietary advice from the AHA
Get summaries like this every morning.
Free AI-powered recaps of Primary Care Update and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.